American Thrombosis And Hemostasisnetwork Inc is located in Rochester, NY. The organization was established in 2007. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2020, American Thrombosis And Hemostasisnetwork Inc employed 42 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations.
For the year ending 12/2020, American Thrombosis And Hemostasisnetwork Inc generated $12.8m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 5.0% each year. All expenses for the organization totaled $13.2m during the year ending 12/2020. While expenses have increased by 7.2% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, American Thrombosis And Hemostasisnetwork Inc has awarded 363 individual grants totaling $28,341,350. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
NON-PROFIT ORGANIZATION DEDICATED TO ADVANCE AND IMPROVE THE CARE OF INDIVIDUALS WITH BLEEDING AND CLOTTING DISORDERS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
CDC SURVEILLANCE - THIS CENTER FOR DISEASE CONTROL COOPERATIVE AGREEMENT FUNDS THE COMMUNITY COUNTS CDC PUBLIC HEALTH SURVEILLANCE PROJECT TO CREATE A UNIFORM SET OF DEMOGRAPHIC AND HEALTH SERVICES UTILIZATION DATA CHARACTERIZING THE POPULATION WITH BLEEDING AND CLOTTING DISORDERS AND TO MONITOR HEALTH INDICATORS OF THESE POPULATIONS. COMMUNITY COUNTS CONSISTS OF THREE PARTS, HTC POPULATION PROFILE, MORTALITY REPORTING, AND THE REGISTRY FOR BLEEDING DISORDERS SURVEILLANCE. MORE THAN 96,000 PATIENTS ARE INVOLVED IN THE CDC SURVEILLANCE PROJECT.
ATHN SYSTEMS - THIS PROGRAM COMPRISES THE SOFTWARE SYSTEMS AND CAPABILITIES REQUIRED AS A STEWARD OF A SECURE NATIONAL DATABASE USED TO SUPPORT CLINICAL OUTCOMES ANALYSIS, RESEARCH, AND PUBLIC HEALTH WITH REPORTING BY OVER 140 TREATMENT CENTERS, GOVERNMENT ENTITIES, AND RESEARCHERS.
HRSA MCHB - THIS NATIONAL HEMOPHILIA PROGRAM IS A COOPERATIVE AGREEMENT WHICH FUNDS THE FIRST NATIONAL HEMOPHILIA PROGRAM COORDINATING CENTER. THE PROJECT CREATES A NATIONAL NETWORK TO OPTIMIZE THE CARE FOR PATIENTS WITH BLEEDING AND THROMBOTIC DISORDERS OVER THEIR LIFETIME AND ACROSS GENERATIONS AND EXTENDS ATHN'S LEADERSHIP FROM THE HTCS AND REGIONS TO A BROADER GROUP OF STAKEHOLDERS SUCH AS PROFESSIONAL ORGANIZATIONS, PATIENT ADVOCACY GROUPS, PAYERS, AND GOVERNMENT PARTNERS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Michael Recht Chief Science Officer | Officer | 40 | $330,700 |
Crystal Watson President And CEO | OfficerTrustee | 40 | $305,374 |
Moses Miles Vp, Research And Informati | Officer | 40 | $226,949 |
Linda Magliocco Vp, Finance And Administra | OfficerTrustee | 40 | $196,114 |
Michelle Hirsh Director, Research Program | 40 | $184,410 | |
Kathleen Vangorden Former Vp, External Affairs | 40 | $179,631 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Miles Ahead Llc Consulting | 12/30/15 | $194,480 |
Earth Vectors Inc Consulting | 12/30/15 | $192,000 |
Kvg Communication Inc Consulting | 12/30/15 | $191,224 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $5,306,347 |
All other contributions, gifts, grants, and similar amounts not included above | $7,416,001 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $12,722,348 |
Total Program Service Revenue | $0 |
Investment income | $88,549 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $12,837,875 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $5,365,955 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $1,059,137 |
Compensation of current officers, directors, key employees. | $308,442 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $2,767,046 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $1,036,099 |
Payroll taxes | $1,039,135 |
Fees for services: Management | $0 |
Fees for services: Legal | $111,342 |
Fees for services: Accounting | $18,450 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $35,237 |
Fees for services: Other | $708,265 |
Advertising and promotion | $0 |
Office expenses | $71,047 |
Information technology | $718,077 |
Royalties | $0 |
Occupancy | $11,634 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $167,659 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $33,808 |
All other expenses | $17,567 |
Total functional expenses | $13,160,458 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $2,386,979 |
Savings and temporary cash investments | $159,335 |
Pledges and grants receivable | $1,661,318 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $134,534 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $5,980,809 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $10,322,975 |
Accounts payable and accrued expenses | $333,762 |
Grants payable | $0 |
Deferred revenue | $3,296,736 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $507,000 |
Other liabilities | $0 |
Total liabilities | $4,137,498 |
Net assets without donor restrictions | $6,185,477 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $10,322,975 |
Over the last fiscal year, American Thrombosis And Hemostasisnetwork Inc has awarded $5,296,505 in support to 69 organizations.
Grant Recipient | Amount |
---|---|
Ypsilanti, MI PURPOSE: DATA MANAGEMENT CAPACITY RESEARCH AND SURVEILANCE | $556,317 |
Santa Anna, CA PURPOSE: DATA MANAGEMENT CAPACITY RESEARCH AND SURVEILANCE | $527,417 |
THE UNIVERSITY OF TEXAS HOUSTON PURPOSE: DATA MANAGEMENT CAPACITY RESEARCH AND SURVEILANCE | $492,128 |
Philadelphia, PA PURPOSE: DATA MANAGEMENT CAPACITY RESEARCH AND SURVEILANCE | $458,956 |
Milwaukee, WI PURPOSE: DATA MANAGEMENT CAPACITY RESEARCH AND SURVEILANCE | $383,975 |
New York, NY PURPOSE: DATA MANAGEMENT CAPACITY RESEARCH AND SURVEILANCE | $372,010 |
Over the last fiscal year, we have identified 3 grants that American Thrombosis And Hemostasisnetwork Inc has recieved totaling $2,773,620.
Awarding Organization | Amount |
---|---|
Indiana Hemophilia And Thrombosis Center Inc Indianapolis, IN PURPOSE: SEE PART IV | $1,798,620 |
Hemophilia Alliance Group Purchasing Organization Inc Lansdale, PA PURPOSE: ENHANCED DATA MANAGEMENT WITHIN HEMOPHILIA TREATMENT CENTERS. | $875,000 |
Positudes Inc Westbury, NY PURPOSE: EDUCATION & RESEARCH | $100,000 |
Organization Name | Assets | Revenue |
---|---|---|
Transcelerate Biopharma Inc West Conshohocken, PA | $49,374,410 | $31,974,894 |
Tri-Institutional Therapeutics Discovery Institute Inc New York, NY | $5,948,211 | $18,048,093 |
Lankenau Institute For Medical Research Wynnewood, PA | $8,021,343 | $9,109,367 |
Coalition Of Cancer Cooperative Groups Philadelphia, PA | $18,946,387 | $14,191,389 |
American Thrombosis And Hemostasisnetwork Inc Rochester, NY | $10,322,975 | $12,837,875 |
Community Partners In Action Inc Hartford, CT | $9,929,187 | $11,184,991 |
Sspc The Society For Protective Coatings Greentree, PA | $24,505,852 | $9,394,855 |
Football Research Inc New York, NY | $10,009,271 | $8,782,918 |
Vermont Oxford Network Inc Burlington, VT | $12,035,958 | $7,981,610 |
Institute For Protein Innovation Inc Boston, MA | $26,558,611 | $24,674,930 |
National Disease Research Interchange Philadelphia, PA | $6,065,530 | $7,121,789 |
Center For Information And Study On Clinical Research Participation Boston, MA | $4,767,267 | $7,850,270 |